https://www.moneycontrol.com/news/business/usfda-inspects-aurobindo-pharmas-new-jersey-based-facility-issues-10-observations-11950681.html
"The observations will be responded to within the stipulated time. The plant is yet to start commercial operations," Aurobindo Pharma said.
Create an account or login to join the discussion